Bio-inspired synthesis of PEGylated Polypyrrole@Polydopamine Nanocomposite as Theranostic agent for T1-Weighted MR imaging guided Photothermal Therapy
Bio-inspired synthesis of PEGylated Polypyrrole@Polydopamine Nanocomposite as Theranostic agent for T1-Weighted MR imaging guided Photothermal Therapy
复制标题
仿生合成聚乙二醇化聚吡咯@聚多巴胺纳米复合材料作为T-1加权磁共振成像引导光热治疗的治疗诊断剂
DOI:
10.1039/c6tb02740g
复制
发表时间:
2017
影响因子:
7
通讯作者:
Haibo Xu
中科院分区:
文献类型:
--
作者:
Zhe Yang;Jinghua Ren;Zhilan Ye;Wei Zhu;Liji Xiao;Li Zhang;Qianyuan He;Zushun Xu;Haibo Xu
Polypyrrole nanoparticle (PPy) based theranostic agents for magnetic resonance imaging (MRI) guided photothermal therapy (PTT) have received increasing attention in recent years. However, the limitations of cost and biocompability still offer us opportunities to improve these agents. Considering the versatile character of polydopamine (PDA), PEGylated PPy@Fe3+-chelated PDA nanocomposites (PPDEs) were designed and prepared in an easy way. PPDE with a uniform core–shell structure could be obtained by adjusting the ratio of dopamine and PPys. In this nanocomplex, the shells confer the nanoparticles with good biocompability and MRI signal enhancing ability. Moreover, the PPy cores play a role in photothermal ablation of tumors. Compared with pure PDA nanoparticles, the PPDEs have higher NIR absorbance and better photothermal capability benefitting from the high photothermal conversion of the cores. Additionally, the obtained PPDEs provide significant MRI signal enhancement for both in vitro and in vivo imaging with high longitudinal relaxivity (r1 = 5.055 mM−1 s−1). After intravenous injection, the PPDEs exhibited valid tumor accumulation, as revealed by MRI and verified by biodistribution analysis. Under NIR irradiation, the PPDEs showed highly effective photothermal ablation of 4T1 cells. Notably, excellent biocompability of the PPDEs was confirmed by a relevant MTT assay and histologic analysis. This work achieved an example of exploiting the inherent advantages of PPy and PDA within a single unit and exploring its potential for T1 MRI-guided PTT.